Contact Us

Please leave a message

×

  • DKSH Reports Strong Core EBIT Growth in Its Full-Year Results 2024

  • Sustainability Report 2024

    DKSH Makes Meaningful Progress Across All Its Four Sustainability Objectives

Industries we serve locally We offer a range of Market Expansion Services to business partners in their respective areas

Did you know that...?

DKSH facts and figures 2024

DKSH and FrontierView Launch Insightful Whitepaper on Vietnam’s Rapidly Growing Healthcare Market

DKSH and FrontierView have published a whitepaper which explores the key drivers behind the growing healthcare market in Vietnam, highlighting challenges and opportunities in regulatory shifts, private sector expansion, and the growing role of retail pharmacies. The paper offers valuable insights for both local and global healthcare companies looking to tap into Vietnam's burgeoning market.

DKSH Healthcare and Euris Unveil CRM & MCE Platform “ConnectPlus” to Revolutionize APAC Healthcare Distribution

DKSH Healthcare and Euris have launched “ConnectPlus”, a complete Customer Relationship Management (CRM) and Multi-Channel Engagement (MCE) platform set to transform healthcare distribution across APAC. This data-driven, agile solution enhances efficiency by providing a comprehensive view of healthcare professionals and optimizing omnichannel engagement strategies. From January 2025, ConnectPlus will strengthen DKSH Healthcare’s commitment to commercial excellence by boosting engagement with clients, customers, and patients across the healthcare ecosystem in Thailand.

DKSH and FrontierView Publish Whitepaper on Southeast Asia as a Growth Accelerator for Global Healthcare Firms

DKSH and FrontierView, a business intelligence and advisory firm, published a whitepaper providing an in-depth assessment of the healthcare status of the Southeast Asia (SEA) region. The research collated in DKSH’s whitepaper provides a comprehensive analysis of the regional healthcare landscape, the challenges and abundant opportunities present, as well as recommended actions for global healthcare firms wanting to enter the market. 

Select a market